Terms: = Prostate cancer AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1
388 results:
1. [Clinical study of artificial intelligence-guided image fusion assisted transperineal prostate biopsy].
Hu J; Zhao XD; Zhou YL; Dong N; Ma MF; Chen YH; Sheng ZC; Dong J; He CQ; Xu S
Zhonghua Nan Ke Xue; 2023 Aug; 29(8):729-735. PubMed ID: 38619521
[TBL] [Abstract] [Full Text] [Related]
2. Cognitive effects of long-term androgen deprivation therapy in older men with prostate cancer.
Pergolizzi D; Flaherty KR; Saracino RM; Root JC; Schofield E; Cassidy C; Katheria V; Patel SK; Dale W; Nelson CJ
Psychooncology; 2024 Mar; 33(3):e6336. PubMed ID: 38520472
[TBL] [Abstract] [Full Text] [Related]
3. Identification of Precise 3D CT Radiomics for Habitat Computation by Machine Learning in cancer.
Prior O; Macarro C; Navarro V; Monreal C; Ligero M; Garcia-Ruiz A; Serna G; Simonetti S; Braña I; Vieito M; Escobar M; Capdevila J; Byrne AT; Dienstmann R; Toledo R; Nuciforo P; Garralda E; Grussu F; Bernatowicz K; Perez-Lopez R
Radiol Artif Intell; 2024 Mar; 6(2):e230118. PubMed ID: 38294307
[TBL] [Abstract] [Full Text] [Related]
4. Apalutamide versus bicalutamide in combination with androgen deprivation therapy for metastatic hormone sensitive prostate cancer.
Ueda T; Shiraishi T; Miyashita M; Kayukawa N; Gabata Y; Sako S; Ogura R; Fujihara A; Okihara K; Ukimura O
Sci Rep; 2024 Jan; 14(1):705. PubMed ID: 38184704
[TBL] [Abstract] [Full Text] [Related]
5. Exploring preventive care practices among unvaccinated individuals in the United States during the COVID-19 pandemic.
Filipas DK; Labban M; Beatrici E; Stone BV; Qian Z; D Andrea V; Ludwig TA; Reis LO; Cole AP; Trinh QD
Vaccine; 2024 Jan; 42(3):441-447. PubMed ID: 38184391
[TBL] [Abstract] [Full Text] [Related]
6. cancer mortality and morbidity among patients with schizophrenia: A hospital-based cohort study, 1992-2020.
Drevinskaite M; Kaceniene A; Patasius A; Stukas R; Germanavicius A; Miseikyte E; Urbonas V; Smailyte G
Acta Psychiatr Scand; 2024 Mar; 149(3):234-243. PubMed ID: 38173088
[TBL] [Abstract] [Full Text] [Related]
7. ARCHERY: a prospective observational study of artificial intelligence-based radiotherapy treatment planning for cervical, head and neck and prostate cancer - study protocol.
Aggarwal A; Court LE; Hoskin P; Jacques I; Kroiss M; Laskar S; Lievens Y; Mallick I; Abdul Malik R; Miles E; Mohamad I; Murphy C; Nankivell M; Parkes J; Parmar M; Roach C; Simonds H; Torode J; Vanderstraeten B; Langley R
BMJ Open; 2023 Dec; 13(12):e077253. PubMed ID: 38149419
[TBL] [Abstract] [Full Text] [Related]
8. Screening history and risk of death from prostate cancer: a nested case-control study within the screening arm of the Finnish Randomized Study of Screening for prostate cancer (FinRSPC).
Talala K; Walter S; Taari K; Tammela TLJ; Kujala P; Auvinen A
Cancer Causes Control; 2024 Apr; 35(4):695-703. PubMed ID: 38063980
[TBL] [Abstract] [Full Text] [Related]
9. Cost-Effectiveness Modeling of prostate-Specific Membrane Antigen Positron Emission Tomography with Piflufolastat F 18 for the Initial Diagnosis of Patients with prostate cancer in the United States.
Yee CW; Harvey MJ; Xin Y; Kirson NY
Pharmacoeconomics; 2024 Feb; 42(2):231-247. PubMed ID: 37934376
[TBL] [Abstract] [Full Text] [Related]
10. Increasing rectum-prostate distance using a hydrogel spacer to reduce radiation exposure during proton beam therapy for prostate cancer.
Narukawa T; Aibe N; Tsujimoto M; Shiraishi T; Kimoto T; Suzuki G; Ueda T; Fujihara A; Yamazaki H; Ukimura O
Sci Rep; 2023 Oct; 13(1):18319. PubMed ID: 37884786
[TBL] [Abstract] [Full Text] [Related]
11. The Effect of Gene Editing by CRISPR-Cas9 of miR-21 and the Indirect Target MMP9 in Metastatic prostate cancer.
Camargo JA; Viana NI; Pimenta R; Guimarães VR; Dos Santos GA; Candido P; Ghazarian V; Romão P; Silva IA; Birbrair A; Srougi M; Nahas WC; Leite KR; Trarbach EB; Reis ST
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834295
[TBL] [Abstract] [Full Text] [Related]
12. Risk of Short-Term prostate-Specific Antigen Recurrence and Failure in Patients With prostate cancer: A Secondary Analysis of a Randomized Clinical Trial.
Sayan M; Huang J; Xie W; Chen MH; Loffredo M; McMahon E; Orio P; Nguyen P; D'Amico AV
JAMA Netw Open; 2023 Oct; 6(10):e2336390. PubMed ID: 37801315
[TBL] [Abstract] [Full Text] [Related]
13. cancer incidence in World Trade Center rescue and recovery workers by race and ethnicity.
Khalifeh M; Goldfarb DG; Zeig-Owens R; Todd AC; Shapiro MZ; Carwile M; Dasaro CR; Li J; Yung J; Farfel MR; Brackbill RM; Cone JE; Qiao B; Schymura MJ; Prezant DJ; Hall C; Boffetta P
Am J Ind Med; 2023 Dec; 66(12):1048-1055. PubMed ID: 37746817
[TBL] [Abstract] [Full Text] [Related]
14. Radiation Therapy Changed the Second Malignancy Pattern in Rectal cancer Survivors.
Ye X; Tan Y; Ma R; Lou P; Yuan Y
Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629753
[No Abstract] [Full Text] [Related]
15. Short-Term DAPT and DAPT De-Escalation Strategies for Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis.
Kuno T; Watanabe A; Shoji S; Fujisaki T; Ueyama H; Takagi H; Deharo P; Cuisset T; Bangalore S; Mehran R; Stone GW; Kohsaka S; Bhatt DL
Circ Cardiovasc Interv; 2023 Sep; 16(9):e013242. PubMed ID: 37609850
[TBL] [Abstract] [Full Text] [Related]
16. Frequency of Biopsy and Tumor Grade Before vs After Introduction of prostate Magnetic Resonance Imaging.
Robinson D; Abdulkareem R; Nasrollah D; Ljung A; Hintze P; Wallby S; Ståhlbrandt H; Frennvall T; Styrke J; Stattin P; Garmo H
JAMA Netw Open; 2023 Aug; 6(8):e2330233. PubMed ID: 37606924
[TBL] [Abstract] [Full Text] [Related]
17. Transcriptomic Signatures Associated With Outcomes in Recurrent prostate cancer Treated With Salvage Radiation, Androgen-Deprivation Therapy, and Enzalutamide: Correlative Analysis of the STREAM Trial.
Bitting RL; Wu Y; Somarelli JA; Proudfoot JA; Liu Y; Davicioni E; George DJ; Armstrong AJ
JCO Precis Oncol; 2023 Aug; 7():e2300214. PubMed ID: 37595184
[TBL] [Abstract] [Full Text] [Related]
18. Archival single-cell genomics reveals persistent subclones during DCIS progression.
Wang K; Kumar T; Wang J; Minussi DC; Sei E; Li J; Tran TM; Thennavan A; Hu M; Casasent AK; Xiao Z; Bai S; Yang L; King LM; Shah V; Kristel P; van der Borden CL; Marks JR; Zhao Y; Zurita AJ; Aparicio A; Chapin B; Ye J; Zhang J; Gibbons DL; ; Sawyer E; Thompson AM; Futreal A; Hwang ES; Wesseling J; Lips EH; Navin NE
Cell; 2023 Aug; 186(18):3968-3982.e15. PubMed ID: 37586362
[TBL] [Abstract] [Full Text] [Related]
19. Acute toxicity comparison of magnetic resonance-guided adaptive versus fiducial or computed tomography-guided non-adaptive prostate stereotactic body radiotherapy: A systematic review and meta-analysis.
Leeman JE; Shin KY; Chen YH; Mak RH; Nguyen PL; D'Amico AV; Martin NE
Cancer; 2023 Oct; 129(19):3044-3052. PubMed ID: 37485697
[TBL] [Abstract] [Full Text] [Related]
20. Impact of Asian Race on Prognosis in De Novo Metastatic prostate cancer.
Ni X; Luu M; Ma W; Zhang T; Wei Y; Freedland SJ; Ye D; Daskivich TJ; Zhu Y
J Natl Compr Canc Netw; 2023 Jul; 21(7):733-741.e3. PubMed ID: 37433430
[TBL] [Abstract] [Full Text] [Related]
[Next]
